drugset / Trial / NCT01493427
Efficacy of Changing to TRAVATAN® From Prior Therapy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the efficacy and tolerability of TRAVATAN® Solution without benzalkonium chloride (BAK) in patients previously on latanoprost 0.005% or bimatoprost 0.01% ophthalmic solution monotherapy.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |